Author:
Tanvetyanon T.,Stiff P.J.
Reference128 articles.
1. Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout);Russell;Lancet,1970
2. Cellular and molecular mechanisms of action of bisphosphonates;Rogers;Cancer,2000
3. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins;Luckman;including Ras. J Bone Miner Res,1998
4. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens;Conte;Oncologist,2004
5. Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound;Green;J Bone Miner Res,1994
Cited by
249 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献